Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.46.6.1887-1895.2002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search